I agree that this site is using cookies. You can find further informations here.
X
Gau, Churn-Shiouh
46  results:
Search for persons X
?
1

Correction: Valuation of the EQ-5D-5L in Taiwan:

Lin, Hsiang-Wen ; Li, Chia-Ing ; Lin, Fang- Ju...
PLOS ONE.  19 (2024)  6 - p. e0305983 , 2024
Link: https://doi.org/10.1371/..
 
?
2

The challenges and opportunities in using real-world data t..:

Crane, Gracy ; Lim, John C. W. ; Gau, Churn-Shiouh..
Current Medical Research and Opinion.  38 (2022)  9 - p. 1543-1551 , 2022
Link: https://doi.org/10.1080/..
 
?
3

Lessons learned from the reimbursement policy for immune ch..:

Huang, Li Ying ; Gau, Churn-Shiouh
International Journal of Technology Assessment in Health Care.  37 (2020)  1 - p. , 2020
Link: https://doi.org/10.1017/..
 
?
4

Outcomes and Impacts of 10-Year HTA Implementation in Taiwa:

Kao, Kai-Ling ; Huang, Li-Ying ; Wu, Yen-Hui.
International Journal of Technology Assessment in Health Care.  35 (2019)  6 - p. 441-445 , 2019
Link: https://doi.org/10.1017/..
 
?
5

Approval of modified-release products by FDA without clinic..:

Wang, Yi-Lin ; Chang, Yi-Ting ; Yang, Shih-Ying...
Regulatory Toxicology and Pharmacology.  103 (2019)  - p. 174-180 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Clinical Trials in Global Drug Developments:

Lai, I-Chun ; Hsiao, Chin-Fu ; Hsu, Lih-jiuan.
CHANCE.  32 (2019)  4 - p. 32-39 , 2019
Link: https://doi.org/10.1080/..
 
?
7

Analysis of refuse-to-file policy for generic drug applicat..:

Sun, I-Chen ; Gau, Churn-Shiouh
Regulatory Toxicology and Pharmacology.  94 (2018)  - p. 33-39 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Valuation of the EQ-5D-5L in Taiwan:

Lin, Hsiang-Wen ; Li, Chia-Ing ; Lin, Fang- Ju...
PLOS ONE.  13 (2018)  12 - p. e0209344 , 2018
Link: https://doi.org/10.1371/..
 
?
9

Stem cell therapy on skin: Mechanisms, recent advances and ..:

Chu, Gong-Yau ; Chen, Yu-Fu ; Chen, Hsiao-Yun...
Journal of Food and Drug Analysis.  26 (2018)  1 - p. 14-20 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Development of the risk-based, phased-in approach for the i..:

Chang, Lin-Chau ; Kang, Jaw-Jou ; Gau, Churn-Shiouh
Regulatory Toxicology and Pharmacology.  77 (2016)  - p. 252-256 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Characterization of patients with duplicated z-hypnotic use..:

Hsieh, Pei-Hua ; Lu, Wan-Hsuan ; Pai, Tsung-Yu...
Journal of Clinical Gerontology and Geriatrics.  7 (2016)  2 - p. 60-63 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Affordable health technology assessment in Taiwan: A model ..:

Chiu, Wen-Ta ; Pwu, Raoh-Fang ; Gau, Churn-Shiouh
Journal of the Formosan Medical Association.  114 (2015)  6 - p. 481-483 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Epidemiology, clinical profile and treatment patterns of ve..:

Chew, Tan-Wei ; Gau, Churn-Shiouh ; Wen, Yu-Wen...
BMC Cancer.  15 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
14

APEC Workshop Report of Good Review Practices on Medical Pr..:

Lin, Hsien-Yi ; Chen, Steven Jun-Yi ; Gau, Churn-Shiouh.
Therapeutic Innovation & Regulatory Science.  49 (2015)  4 - p. 483-492 , 2015
Link: https://doi.org/10.1177/..
 
?
15

The evolution and challenges for the international harmoniz..:

Chang, Lin-Chau ; Kang, Jaw-Jou ; Gau, Churn-Shiouh
Regulatory Toxicology and Pharmacology.  73 (2015)  3 - p. 947-952 , 2015
Link: https://doi.org/10.1016/..
 
1-15